You are here

2019

Spineology Provides Duo™ System Commercial and Post-Market Update

ST. PAUL, Minn.--( BUSINESS WIRE )--Spineology Inc., an innovator in anatomy-conserving spine surgery, is excited to announce that over 125 lateral interbody fusion cases have been successfully completed using its unique Duo™ Lumbar Interbody Fusion System. The Duo System features the only implant on the market that combines PEEK, titanium, and graft containment mesh elements. The implant, which is filled with bone post-insertion, creates a large, endplate-conforming graft pack that expands up to 30mm in width to maximize load sharing and minimize point-loading. These features are designed to reduce subsidence, improve spinal correction maintenance and support a robust fusion. In...

Spineology Mesh Interbody Fusion Technologies Yield Excellent/Good Patient Satisfaction Scores in Excess of 85 Percent

ST. PAUL, Minn.--( BUSINESS WIRE )--Spineology Inc., an innovator in anatomy-conserving spine surgery, is excited to announce that two abstracts highlighting the company’s proprietary mesh technologies were presented during the 2019 International Society for the Advancement of Spine Surgery (ISASS) Annual Meeting, which took place this past week in Anaheim, California. In a poster titled Patient-Reported Outcomes Comparing Predominant Back Pain or Radiculopathy at Baseline: 12-month Trial Results of a Novel Expandable Mesh Lumbar Interbody Grafting Device , co-authored by John Chi, M.D., MPH, (Brigham and Women’s Hospital); Pierce Nunley, M.D. (Spine Institute of Louisiana); Marcus Stone, Ph.D. (Spine Institute...

Outcomes of Spineology U.S. Clinical Trial for Interbody Fusion Shared at 2019 SMISS Meeting

ST. PAUL, Minn. November 2019--( BUSINESS WIRE )--Spineology Inc., an innovator in anatomy-conserving spine surgery, is pleased to announce that John Chi, M.D., MPH, Associate Professor of Neurosurgery at Harvard Medical School and the Director of Neurosurgical Spinal Oncology at Brigham and Women’s Hospital in Boston, Massachusetts, presented 24-month outcomes data from Spineology’s SCOUT clinical trial at last week’s Society for Minimally Invasive Spine Surgery (SMISS) Annual Meeting in Las Vegas, Nevada. The SCOUT study (Spineology Clinical Outcomes Trial), conducted under an FDA-approved IDE protocol, is a prospective, multi-center, non-randomized performance goal investigation designed to evaluate safety and effectiveness outcomes...

Unique Study Nominated for Best Paper at SMISS by Providing Rare Illustration of Patient-Reported Outcomes in Lateral Access Surgery

ST. PAUL, Minn. November 2019--( BUSINESS WIRE )--Spineology Inc., an innovator in anatomy-conserving spine surgery, is excited to announce that “A Prospective, In-Depth Analysis of Perioperative Anterior Thigh Symptoms Associated with a Direct Lateral Access Approach for Lumbar Interbody Fusion” was nominated for Best Paper at the Society for Minimally Invasive Spine Surgery (SMISS) 2019 annual meeting in Las Vegas, NV. The paper, presented by Dr. Pierce Nunley of the Spine Institute of Louisiana, details the unique protocol being used, and data being collected, in the Duo Clinical Study (RaDical), Spineology’s prospective, multi-center, IRB-approved post-market study using the Duo System...